References
This page is intended for Irish Healthcare Professionals only
1. Cariban, Summary of Product Characteristics (SPC)
August 2023
2. Hyperemesis and Nausea/Vomiting In Pregnancy Guidelines. Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and the Clinical Strategy and Programmes Division, Health Service Executive.
2018
3. Saz-Leal, P. et al. Bioavailability of Cariban® Capsules: A Modified-Release Fixed-Dose Combination of Doxylamine and Pyridoxine to Relieve Nausea and Vomiting During Pregnancy. Drugs R D 23, 185–195 (2023).
https://doi.org/10.1007/s40268-023-00425-7.
4. NICE guideline NG201. Management of nausea and vomiting in pregnancy.
August 2021
5. Lacasse, A., Bérard, A. Validation of the nausea and vomiting of pregnancy specific health related quality of life questionnaire. Health Qual Life Outcomes 6, 32 (2008).
https://doi.org/10.1186/1477-7525-6-32
6. Campbell K, Rowe H, Azzam H, Lane CA. The Management of Nausea and Vomiting of Pregnancy. J Obstet Gynaecol Can.
2016;38(12):1127-37.
7. Cariban, Patient Information Leaflet (PIL)
June 2023
8. Koren G, Clark S, Hankins GDV, et al. Effectiveness of delayed release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol
2010;203:571.e1-7.
9. RCOG GREEN-TOP GUIDELINES. The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69).
https://doi.org/10.1111/1471-0528.17739
Ensure you are viewing relevant content
Please select from the following options:
Mailing list sign up
Keep up to date with the latest Cariban news and information by joining our mailing list.
Queries regarding Cariban?
If you have any questions regarding Cariban please contact us directly.